(Q34825028)

English

Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: evidence for and against the combination in the treatment of hypertension and proteinuria.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12217259%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Europe PubMed Central

Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: evidence for and against the combination in the treatment of hypertension and proteinuria (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12217259%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Niels Holmark Andersen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12217259%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Carl Erik Mogensen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12217259%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12217259%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Current Hypertension Reports

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12217259%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12217259%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12217259%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

394-402

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12217259%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0070-X

21 January 2018

Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0070-X

21 January 2018

Angiotensin II type 1 receptor blockers

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0070-X

21 January 2018

Role of angiotensin subtype 2 receptor in neointima formation after vascular injury

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0070-X

21 January 2018

Additive Effects of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin II Antagonism on Blood Pressure and Renin Release in Sodium-Depleted Normotensives

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0070-X

21 January 2018

Add-on angiotensin receptor blockade with maximized ACE inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0070-X

21 January 2018

The comparative pharmacology of angiotensin II receptor antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II receptor antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to report randomized controlled trials. The CONSORT statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive effects of losartan and enalapril on blood pressure and plasma active renin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological demonstration of the additive effects of angiotensin-converting enzyme inhibition and angiotensin II antagonism in sodium depleted healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of aldosterone in the remnant kidney model in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue angiotensin system in cardiovascular medicine. A paradigm shift?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACE inhibitors versus AT(1) receptor antagonists in patients with chronic renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34825028&oldid=2197057921"